Integral BioSystems Announces Trademark Protection for its Intellectual Property Subsidiary

Boston area CRO Integral BioSystems, LLC announces that the name of its Intellectual Property subsidiary, Patents Etcetera, has been granted trademark protection by the United States Patent and Trademark Office.
 
 
Spread the Word
Listed Under

Tags:
Intellectual Property
Trademark
Biotechnology
Cro
Formulation

Industrys:
Biotech
Science
Legal

Location:
Bedford - Massachusetts - US

Sept. 8, 2010 - PRLog -- Integral BioSystems Announces Trademark Protection for its Intellectual Property Subsidiary

By Integral BioSystems, LLC
Dated: September 8, 2010

Boston area CRO Integral BioSystems, LLC announces that the name of its Intellectual Property subsidiary, Patents Etcetera, has been granted trademark protection by the United States Patent and Trademark Office.

“With the Patents Etcetera brand now trademark protected, and with like protection for Integral BioSystems, LLC now pending in the United States Patent and Trademark Office, we anticipate a fruitful relationship for years to come under each firm’s respective banner.”

-Dave Karasic, J.D.
V.P. Business Development/Legal/I.P.
Integral BioSystems, LLC
781-879-4677

About Patents Etcetera
Located near Boston, Massachusetts, Patents Etcetera is an intellectual property firm founded in 2006 to provide expert patent filing services to individual inventors, seed companies, pre- start-ups and small businesses. Since its inception, Patents Etcetera has filed patent applications in the areas of drug delivery, drug dosage forms in ophthalmics, dentistry and vaccines, nanotechnology products and mechanical device designs.  By teaming up with Integral BioSystems, LLC in 2008, Patents Etcetera has been able to expand its reach into the Boston area’s growing biotechnology-based industry.

About Integral BioSystems, LLC
Integral BioSystems, LLC, founded in 2008, has adopted a translational medicinal approach to drug development, customizing delivery systems to accomplish the biologically effective objectives of the therapy. Drug delivery systems are customized to achieve sustained release or targeted, tissue-focused delivery, or fast-release/instant delivery, depending upon the desired product attributes. The company has a network of manufacturers/analytical houses for pharmaceutics that can fast-track the manufacture and release of the sterile dosage form for first-in-man trials.

# # #

A Boston area-based contract research organization, Integral BioSystems specializes in the development of ophthalmic, transdermal, intravenous, intranasal and oral dosage forms. Additionally, we offer services in intellectual property and contracts.
End
Source:
Email:***@integralbiosystems.com
Phone:781-879-4677
Zip:01730
Account Email Address Verified     Disclaimer     Report Abuse
Page Updated Last on: Sep 09, 2010
Integral BioSystems, LLC PRs
Trending News
Top Daily News
Top Weekly News



Like PRLog?
9K2K1K
Click to Share